Can India lead the way in neglected diseases innovation?

Thomas, Zakir; Saha, Gautam; Gopakumar, Kappoori Madhavan; Ganguly, Nirmal Kumar

doi:10.1136/bmj.k5396

Cited by 15 publications

(16 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The way forward would be to provide a roadmap that empirically gives a clear direction of increased surveillance in cholera hotspots and detecting new cases and outbreaks. The action point from the policymaker’s perspective should be an integrated approach of research and development and socioeconomic development [ 36 ]. A surveillance system combined with a sustainable vaccination program that effectively delivers vaccinations to the most endemic areas of cholera is needed.…”

Section: Way Forwardmentioning

confidence: 99%

Spread and Endemicity of Cholera in India: Factors Beyond the Numbers

Saha

Ganguly

2021

The Journal of Infectious Diseases

Self Cite

View full text Add to dashboard Cite

Presently, Cholera outbreaks account for 1.3 to 4.0 million cases and causes between 21,000 and 143,000 deaths worldwide. Cholera is preventable by proper sanitization and immunization however in many developing nations such as India, Cholera disease is endemic. The surveillance system in India does not adequately capture the actual number of cases. Consequently, it is important to utilize limited public health resources correctly in India and other developing counties more effectively to reach vulnerable communities. Here, we analyse how studies make sense of Cholera transmission and spread in India from 1996-2015. Further, how a more sensitive surveillance system can contribute to cholera eradication by giving rise to outbreak preparedness.

show abstract

Section: Way Forwardmentioning

confidence: 99%

Spread and Endemicity of Cholera in India: Factors Beyond the Numbers

Saha

Ganguly

2021

The Journal of Infectious Diseases

Self Cite

View full text Add to dashboard Cite

show abstract

“…Innovation now a days is controlled by the market and do not have consistency in reaching the patients. 20…”

Section: Resources: Training and Capacity Buildingmentioning

confidence: 99%

SARS-CoV-2 a public health emergency: challenges in vaccination in Indian setup

Dakshinamurthy

Boratne

Kanagat

2021

Int J Community Med Public Health

View full text Add to dashboard Cite

WHO is working in collaboration with scientists, business, and global health organizations to fasten the pandemic response. India has approved two vaccines, Covishield and Covaxin for emergency use to fight COVID-19 pandemic in the country. Even when vaccinations are provided free of cost in PHCs, some social stigma always present in communities which make hardest-to-reach remote rural areas. Enhancing access to vaccination services, provider-based interventions and increasing community demand are some areas of concern. In spite of all recommendations, certain challenges like safety of vaccines, human rights and law, trust and prevention of distrust etc. remain to be solved before planning to introduce a new vaccine in the public health system. In the first phase of the vaccination drive, frontline workers nearly from both government and private sector will get vaccinated. These include cleaners, police and paramilitary, home guards, disaster management volunteers and other jawans in civil defence, and revenue officials associated with containment and surveillance. In the second and third stage, those above 45 years of age with comorbidities and then without comorbidities will be vaccinated. Later people in age group of more than 18 years will get vaccine.

show abstract

“…South Asia has a unique role in combating these diseases globally as well as regionally, given the high disease burden and regional expertise in end-to-end solutions, from drug discovery and clinical studies through to regulation, manufacture, and distribution. Such “bench to bedside” leadership could grow rapidly with supportive policy for research and development in neglected diseases 9. We are launching this collection at a meeting in New Delhi in January 2019, where stakeholders engaged in neglected diseases control, research, and advocacy in South Asia will come together to celebrate the successes so far and plan for further collaborative action.…”

Section: Better Systemsmentioning

confidence: 99%